Claudine J. Isaacs

Claudine Isaacs practices at Medstar Georgetown Medical Center in Washington, District of Columbia.

Claudine Isaacs' NPI, 1164414751, was assigned on August 19, 2005. Claudine Isaacs holds District of Columbia license 20270.

Claudine Isaacs' primary practice is Medstar Georgetown Medical Center, at 3800 Reservoir NW Rd, Washington, DC 20007 in District Of Columbia County. The practice phone is (202) 444-1400.

Claudine Isaacs' primary practice is Medstar Georgetown Medical Center in Washington, District of Columbia. Claudine Isaacs is also affiliated with MedStar Washington Hospital Center. The medical group on file is MedStar Medical Group. Dmand AI also links Claudine Isaacs to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Claudine Isaacs practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Claudine Isaacs' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Claudine Isaacs is licensed in District of Columbia.

CMS data shows 120 Medicare services from Claudine Isaacs across 3 procedure codes in 2024, all of them office visits, for 81 Medicare patients. Medicare paid $11,095 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 81 Medicare patients who saw Claudine Isaacs in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have cancer, and 68% have high cholesterol. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Claudine Isaacs' median patient age at 56, with 96% women.

In 2024, Claudine Isaacs wrote 58 Medicare Part D claims for 28 patients. 93% of them were for generic drugs. CMS names the drug for 41 of them, across 2 drugs with 11 or more claims each, at $1,802 in total drug cost. In 2023, CMS named 32 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Claudine Isaacs for performance year 2024, reported as part of a group. Claudine Isaacs accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 406 general payments to Claudine Isaacs from 13 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. Genentech, Inc. paid the most, $177,463. It also lists 9 research payments totaling $27,552 from 2017 to 2023.